Quantcast

Latest diabetes care Stories

2014-06-25 23:13:12

STRIATUS/JBJS, Inc. is proud to announce that the American Diabetes Association (ADA)—publishers of the journals Diabetes®, Diabetes Care®, Clinical Diabetes®, and Diabetes Spectrum®—has signed on to participate in PRE-val. Diabetes and Diabetes Care will be the first two ADA journals to participate. Needham, MA (PRWEB) June 25, 2014 Publishers of leading diabetes journals to use new tool to validate peer review. STRIATUS/JBJS, Inc. is proud to announce that the...

2014-06-19 08:30:01

Latest delivery device advancement in the basal insulin category PLAINSBORO, N.J., June 19, 2014 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced the availability of its newest prefilled insulin delivery device Levemir(®) FlexTouch(®) (insulin detemir [rDNA origin] injection) in the United States. This device represents an advancement in insulin delivery and is based on years of feedback from endocrinologists, certified diabetes educators, primary care...

2014-06-09 08:29:57

· Data for investigational compounds LY2963016, empagliflozin and empagliflozin/linagliptin combination tablet highlight robust alliance pipeline RIDGEFIELD, Conn. and INDIANAPOLIS, June 9, 2014 /PRNewswire/ -- More than 40 posters, abstracts and oral presentations will demonstrate the breadth and depth of the Boehringer Ingelheim (BI) and Eli Lilly and Company (NYSE: LLY) diabetes portfolio at the 74(th) American Diabetes Association (ADA) Scientific Sessions® in San Francisco, June 13-17....

2014-05-06 16:33:18

SAN DIEGO, May 6, 2014 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today reported its financial results for the quarter ended March 31, 2014. For the quarter ended March 31, 2014, sales grew 48 percent to $8.1 million, compared to $5.5 million for the same period of 2013. For the quarter ended March 31, 2014, pump shipments grew 102 percent to 1,723 t:slim Pumps, compared to 852 pumps for the same...

2014-05-01 08:33:38

- Announces revenues of $2.072 billion, an increase of 3.6 percent, or 5.1 percent on a foreign currency-neutral basis. FRANKLIN LAKES, N.J., May 1, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.072 billion for the second fiscal quarter ended March 31, 2014, representing an increase of 3.6 percent from the prior-year period, or 5.1 percent on a foreign currency-neutral basis....

2014-04-23 12:29:24

Program Also Led to Better Blood Glucose Control and Greater Reductions in Heart Disease Risk Factors; Jenny Craig for Type 2 Now Available to Consumers CARLSBAD, Calif., April 23, 2014 /PRNewswire/ -- Study Highlights: -- After one year, Jenny Craig participants lost more than three times as much weight as the Usual Care group. -- Study participants following Jenny Craig's lower carbohydrate menu significantly reduced their HbA1c levels from 7.3% to 6.6%, while...

2014-04-16 12:29:41

CHARLOTTE, N.C., April 16, 2014 /PRNewswire/ -- On April 10, 2014 the U.S. Food & Drug Administration (FDA) issued a "Closeout" letter to Prodigy Diabetes Care to formally conclude the regulatory action that resulted in a Warning Letter on February 22, 2013. Since the original site inspection of Prodigy in March 2012, and in response to the February 2013 letter, Prodigy has worked with the FDA to address and correct the issues identified through that inspection. The FDA Atlanta...

2014-04-15 08:28:57

Sales of $18.1 Billion increased 3.5% Versus 2013 First Quarter; NEW BRUNSWICK, N.J., April 15, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a...

2014-04-08 15:47:41

Researchers at the University of Adelaide have discovered that a common treatment for people with type 2 diabetes could cause longer-than-normal periods of the low blood sugar reaction hypoglycemia, which may result in increased health risks to people with diabetes. The treatment is the use of the peptide GLP-1 (glucagon-like peptide 1) in combination with insulin, which is now used throughout the world as a standard therapy for patients with type 2 diabetes. A team of researchers at...

2014-04-08 12:31:28

NOORDWIJK, The Netherlands, April 8, 2014 /PRNewswire/ -- Urgent need to mobilise and involve people with diabetes in partnership efforts to face the challenges of the diabetes pandemic Link to the multimedia release [http://www.novonordisk.com/press/press-releases/DAWN2-amhg.asp ] Participants at the 5th International DAWN(TM) Summit (Diabetes Attitudes Wishes and Needs) today pledged to work together to make person-centred diabetes care a reality for the 382...


Latest diabetes care Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »
Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related